• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by BNB Plus Corp.

    1/30/26 4:06:16 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary
    Get the next $BNBX alert in real time by email
    S-8 1 tm264258d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on January 30, 2026

     

    Registration No. 333- _______

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

     

     

    BNB Plus Corp.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware

    (State or other jurisdiction of
    incorporation or organization)

     

    59-2262718
    (I.R.S. Employer Identification Number)

     

    50 Health Sciences Drive  11790
    Stony Brook, New York   (Zip Code)
    (Address of Principal Executive Offices)  

     

    Applied DNA Sciences, Inc. 2020 Equity Incentive Plan

    (Full title of the plan)

     

    Clay Shorrock

    Chief Executive Officer and President

    BNB Plus Corp.

    50 Health Sciences Drive

    Stony Brook, New York 11790

    Telephone: (631) 240-8800

    (Name and address of agent for service)

    (Telephone number, including area code, of agent for service)

     

    Copies to:

     

    Alexander R. McClean, Esq.

    Margaret K. Rhoda, Esq.

    Harter Secrest & Emery LLP

    1600 Bausch & Lomb Place

    Rochester, New York 14604

    Tel: (585) 232-6500

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨   Accelerated filer ¨
    Non-accelerated filer x   Smaller reporting company x
          Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Registration Statement relates to the registration of an additional 5,000,000 shares of common stock, $0.001 par value per share (the “Common Stock”), for future issuance pursuant to awards under the 2020 Equity Incentive Plan (the “2020 Plan”) of BNB Plus Corp. (the “Company”). Such additional shares being registered are of the same class as other securities of the Company for which a Registration Statement on Form S-8 relating to the same employee benefit plan is effective. In accordance with General Instruction E to Form S-8, the contents of the Company’s previous Registration Statements on Form S-8 related to the 2020 Plan (Commission File Nos. 333-249365, 333-282414, and 333-288938), filed on October 7, 2020,  September 30, 2024, and July 25, 2025, respectively, with the U.S. Securities and Exchange Commission (the “Commission”), are incorporated herein by reference and made part of this Registration Statement, except as amended or otherwise modified or superseded hereby. Effective as of December 12, 2025, the date of the approval by the Company’s stockholders of the amendment of the 2020 Plan, the total number of shares of Common Stock that may be issued under the 2020 Plan has been increased to 5,200,500 shares of Common Stock from 200,500 shares of Common Stock.

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3.   Incorporation of Documents by Reference.

     

    The Commission allows us to “incorporate by reference” the information we file with them, which means that we can disclose important information to you by referring to those documents. The information incorporated by reference is considered to be part of this Registration Statement, and later information filed with the Commission will update and supersede this information. We hereby incorporate by reference into this Registration Statement the following documents and information previously filed with the Commission:

     

    (i) Our Annual Report on Form 10-K for the fiscal year ended September 30, 2025 filed with the Commission on December 22, 2025;
     
    (ii) Our Current Reports on Form 8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that are related to such items) filed with the Commission on on October 1, 2025, October 6, 2025 October 23, 2025, November 4, 2025, November 10, 2025, November 17, 2025, December 15, 2025, and January 22, 2026; and
     
    (iii) The description of our Common Stock contained in our registration statement on Form 8-A (File No. 001-36745) filed on November 13, 2014, pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description.    

     

    In addition to the foregoing, all documents filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than, in each case, documents or information, including, without limitation, any applicable exhibits, deemed to have been “furnished” and not “filed” in accordance with the rules and regulations issued by the Commission), subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.

     

    Any statement contained in this Registration Statement or in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is, or is deemed to be, incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

     

     

     

    Item 8. Exhibits.

     

    Item 8. Exhibits.

     

    Exhibit
    No.
      Exhibit
    Description
    3.1+   Conformed version of Certificate of Incorporation of Applied DNA Sciences, Inc., as most recently amended by the Eighth Certificate of Amendment, effective June 2, 2025 (incorporated by reference to Exhibit 3.1 of the registrant’s Registration Statement on Form S-8 filed on July 25, 2025)
         
    3.2   Conformed version of By-Laws, as amended by the Certificate of Amendment to the By-Laws, effective November 7, 2024 (incorporated by reference to Exhibit 3.2 of the registrant’s Registration Statement on Form S-1 filed on November 19, 2024)
         
    5.1*   Opinion of Harter Secrest & Emery LLP
         
    10.1*^   Conformed version of Applied DNA Sciences, Inc. 2020 Equity Incentive Plan, as most recently amended by the Amendment to the Applied DNA Sciences, Inc. 2020 Equity Incentive Plan, effective December 12, 2025
         
    23.1*   Consent of Harter Secrest & Emery LLP (contained in Exhibit 5.1)
         
    23.2*   Consent of Marcum LLP, independent registered public accounting firm
         
    23.3*   Consent of CBIZ CPAs P.C., independent registered public accounting firm
         
    24.1*   Power of Attorney (included as part of signature page to this Registration Statement)
         
    107*   Filing Fee Table

     

    * Filed herewith.

     

    ^ Management contract or compensatory plan or arrangement.

     

    + This exhibit is being filed pursuant to Item 601(b)(3)(i) of Regulation S-K which requires a conformed version of the Company’s charter reflecting all amendments in one document. The exhibit reflects the Company’s Certificate of Incorporation, as previously amended, as most recently amended by the ninth Certificate of Amendment, effective November 13, 2025.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Stony Brook, State of New York, on January 30, 2026.

     

    BNB Plus Corp.  
       
    By: /s/ Clay Shorrock  
      Clay Shorrock  
      Chief Executive Officer and President  

     

    POWER OF ATTORNEY

     

    Each person whose signature appears below appoints Clay Shorrock and Beth M. Jantzen and each of them, any of whom may act without the joinder of the other, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and any registration statement (including any amendment thereto) for this offering that is to be effective upon filing pursuant to Rule 462 under the Securities Act and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or would do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them of their or his or her substitute and substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature   Title   Date
             
    /s/ Clay Shorrock   Chief Executive Officer and President   January 30, 2026
    Clay Shorrock   (Principal Executive Officer)    
             
    /s/ Beth M. Jantzen   Chief Financial Officer   January 30, 2026
    Beth M. Jantzen   (Principal Financial Officer and Principal Accounting Officer)    
             
    /s/ Joshua Kruger   Chairman of the Board of Directors   January 30, 2026
    Joshua Kruger        
             
    /s/ Robert B. Catell   Director   January 30, 2026
    Robert B. Catell        
             
    /s/ Joseph D. Ceccoli   Director   January 30, 2026
    Joseph D. Ceccoli        
             
    /s/ Judith Murrah   Director   January 30, 2026
    Judith Murrah        
             
    /s/ Yacov A. Shamash   Director   January 30, 2026
    Yacov A. Shamash        

     

     

     

    Get the next $BNBX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNBX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BNBX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Jantzen Beth

    4 - BNB PLUS CORP. (0000744452) (Issuer)

    12/16/25 4:05:28 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Chief Executive Officer Shorrock Clay

    4 - BNB PLUS CORP. (0000744452) (Issuer)

    12/16/25 4:05:49 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    New insider Kruger Joshua claimed ownership of 75,302 shares (SEC Form 3)

    3 - BNB PLUS CORP. (0000744452) (Issuer)

    11/19/25 7:36:22 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $BNBX
    SEC Filings

    View All

    Digital Asset Virtual Investor Conference: Presentations Now Available for Online Viewing

    NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Digital Asset Virtual Conference, held January 27th are now available for online viewing. REGISTER AND VIEW PRESENTATIONS HERE The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section. Select companies are accepting 1x1 management meeting requests through January 30th. Please schedule 1x1 meetings here January 27th PresentationTicker(s)Africa Bitcoin Corporation Limited(OTCQB:AFBCF, JSE: BAC))VersaBank(NASDAQ:VBNK

    1/28/26 8:35:00 AM ET
    $AVX
    $BNBX
    $VBNK
    Finance: Consumer Services
    Finance
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

    Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital Asset Virtual Investor Conference hosted by Virtual InvestorConferences.com, on January 27th, 2026 at 1:00PM EST. DATE: January 27th, 2026 TIME: 1:00PM EST Register here Mr. Horsman and Mr. Kruger will be available for 1x1 meetings on January 27-29. Participants may schedule 1x1 Meetings here. The Digital Asset Virtual Investor Conference is a live,

    1/27/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital Asset Virtual Investor Conference hosted by Virtual InvestorConferences.com, on January 27th, 2026 at 1:00PM EST. DATE: January 27th, 2026 TIME: 1:00PM EST Register here Mr. Horsman and Mr. Kruger will be available for 1x1 meetings on January 27-29. Participants may schedule 1x1 Meetings Here The Digital Asset Virtual Investor Conference is a live, interactive online event where investors are invited to ask the company questions in real-time. If att

    1/27/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 filed by BNB Plus Corp.

    S-8 - BNB PLUS CORP. (0000744452) (Filer)

    1/30/26 4:06:16 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. filed SEC Form 8-K: Leadership Update

    8-K - BNB PLUS CORP. (0000744452) (Filer)

    1/22/26 4:10:46 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form 424B3 filed by BNB Plus Corp.

    424B3 - BNB PLUS CORP. (0000744452) (Filer)

    12/30/25 8:27:25 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Leadership Updates

    Live Leadership Updates

    View All

    Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

    Rebrand Aligned with Yield-Focused BNB Treasury and BNBX Ticker Appointment Strengthens DeFi Leadership Applied DNA Sciences, Inc. (NASDAQ:BNBX) (the "Company") today announced that it will change its name to BNB Plus Corp. ("BNB Plus"), reflecting the Company's commitment to delivering a yield-optimized, BNB-based digital asset treasury strategy leveraging the Binance ecosystem. Alongside the rebrand, the Company also announced the appointment of Josh Kruger as Chairman of the Board. Mr. Kruger has deep expertise in managing blockchain-native assets for yield and capital efficiency. He is the founder of OnChain Alpha and previously served as Head of Trading at Coral Capital, which wa

    11/17/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Financials

    Live finance-specific insights

    View All

    BNB Plus Provides BNB Treasury and Operational Updates

    Company Acquires 3,349 Additional BNB Tokens LineaRx Subsidiary Expected to Narrow Losses and Approach Profitability in FY26Q1 Company Launches New Corporate Website and Branding BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc. ("LineaRx") subsidiary, and the launch of a new corporate website and branding. Significant Addition to BNB Treasury The Company has opportunistically deployed an additional approximately $3 million to acquire additional BNB tokens at an average price of approximately $895 per token, further strengthening the C

    12/9/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

    Company Launches BNBX.io to Provide Robust Real-Time Portfolio and Company Metrics Company Recently Closed Up to $58 Million Private Placement to Launch Yield-Focused BNB Treasury Applied DNA Sciences, Inc. (NASDAQ:BNBX) ( "BNBX" or the "Company") today announced the launch of BNBX.io, which provides real-time portfolio metrics updating the market on the Company's BNB treasury holdings, key valuation metrics, and detailed information about the capitalization structure of the Company (the "Dashboard"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028565774/en/ "The launch of our Dashboard reflects BNBX's commitment to re

    10/28/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

    Company Officially Launches Yield-Focused Digital Asset Treasury Strategy Streamlines Operations, Achieving Approximately $2.9 Million in Annualized Cost Savings Applied DNA Sciences, Inc. (NASDAQ:BNBX) ("Applied DNA", "BNBX" or the "Company"), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced the successful close of its previously announced private investment in public equity ("PIPE") financing led by institutional DeFi and TradFi investors. The PIPE resulted in gross proceeds of approximately $27 Million to the Company, before deducting placement agent fees and other offering e

    10/22/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary